FitBiomics, a leading biotechnology company focused on harnessing the power of the human microbiome for improved health and performance, is announcing the appointment of Dr. Allison Brager and Dr. Mike Molloy to its team of esteemed Scientific Advisors.
Dr. Allison Brager is a renowned sleep scientist, exercise physiologist, and Deputy Science Officer with a wealth of expertise in human performance optimization. With a Ph.D. in Experimental Psychology and a background in neurobiology, Dr. Brager's groundbreaking research in sleep and circadian rhythms has garnered international recognition. Her work has been instrumental in understanding the crucial role of sleep in human health, cognitive function, and athletic performance.
Dr. Mike Molloy is a distinguished microbiologist and immunologist whose research focuses on the interplay between the gut microbiome and human health. He holds a Ph.D. in Microbiology and Immunology and has made significant contributions to the understanding of the gut microbiome's impact on various health conditions. “"For years, we've known that gut health was critical to overall health in the human body. However, we're now learning that a fit gut also drives a fit body as well, and the research around Veillonella leads the field. I'm excited to joining Fitbiomics as an advisor to help educate the fitness community around this incredible advancement in the field." Dr. Molloy's expertise in microbiology and immunology will be invaluable to FitBiomics as the company continues to develop innovative microbiome-based solutions.
FitBiomics is at the forefront of microbiome research, dedicated to harnessing the potential of beneficial bacteria found in the human gut to develop novel products that enhance overall wellness. The addition of Dr. Brager and Dr. Molloy to the Scientific Advisory Board further strengthens the company's commitment to scientific excellence and innovative advancements in microbiome science. On joining FitBiomics, Dr. Brager noted, “FitBiomics is becoming the tip of the spear force in the human performance space using next-generation technology and performance nutrition science to help every human unleash their true potential.”
"We are thrilled to welcome Dr. Allison Brager and Dr. Mike Molloy to our team of scientific advisors," said Dr. Jonathan Scheiman, CEO of FitBiomics. "Their deep knowledge and expertise in sleep science, exercise physiology, and microbiology will provide invaluable insights as we continue to explore the profound connections between the microbiome, human performance, and overall health. We are confident that their contributions will greatly enhance our research and development efforts."
As Scientific Advisors for FitBiomics, Dr. Brager and Dr. Molloy will play a key role in guiding the company's research initiatives, advising on product development strategies, and contributing to the advancement of microbiome science. Their expertise will help shape the future direction of FitBiomics, ensuring the delivery of scientifically validated solutions that have a positive impact on people's lives.
About FitBiomics:
FitBiomics is a leading biotechnology company dedicated to leveraging the power of the human microbiome for enhanced health and performance. The company's innovative research and development efforts focus on the identification and development of unique bacterial strains found in the gut, with the aim of creating novel products that improve overall well-being. FitBiomics is committed to scientific excellence and collaborates with world-class experts to push the boundaries of microbiome science.
